Literature DB >> 8795592

More immunotherapy for multiple sclerosis.

R A Hughes, B Sharrack.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8795592      PMCID： PMC486544          DOI： 10.1136/jnnp.61.3.239

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  37 in total

1.  An assessment of disability rating scales used in multiple sclerosis.

Authors:  D A Francis; P Bain; A V Swan; R A Hughes
Journal:  Arch Neurol       Date:  1991-03

2.  Evoked potentials predict the clinical changes in a multiple sclerosis drug study.

Authors:  M R Nuwer; J W Packwood; L W Myers; G W Ellison
Journal:  Neurology       Date:  1987-11       Impact factor: 9.910

3.  MRI dynamics of brain and spinal cord in progressive multiple sclerosis.

Authors:  D Kidd; J W Thorpe; B E Kendall; G J Barker; D H Miller; W I McDonald; A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-01       Impact factor: 10.154

4.  Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.

Authors:  S L Hauser; D M Dawson; J R Lehrich; M F Beal; S V Kevy; R D Propper; J A Mills; H L Weiner
Journal:  N Engl J Med       Date:  1983-01-27       Impact factor: 91.245

5.  A neurologic rating scale (NRS) for use in multiple sclerosis.

Authors:  J C Sipe; R L Knobler; S L Braheny; G P Rice; H S Panitch; M B Oldstone
Journal:  Neurology       Date:  1984-10       Impact factor: 9.910

6.  New diagnostic criteria for multiple sclerosis: guidelines for research protocols.

Authors:  C M Poser; D W Paty; L Scheinberg; W I McDonald; F A Davis; G C Ebers; K P Johnson; W A Sibley; D H Silberberg; W W Tourtellotte
Journal:  Ann Neurol       Date:  1983-03       Impact factor: 10.422

7.  Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study.

Authors:  A J Thompson; A G Kermode; D G MacManus; B E Kendall; D P Kingsley; I F Moseley; W I McDonald
Journal:  BMJ       Date:  1990-03-10

8.  Upper extremity function in multiple sclerosis: improving assessment sensitivity with box-and-block and nine-hole peg tests.

Authors:  D E Goodkin; D Hertsgaard; J Seminary
Journal:  Arch Phys Med Rehabil       Date:  1988-10       Impact factor: 3.966

9.  A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosis.

Authors:  M B Bornstein; A Miller; S Slagle; M Weitzman; H Crystal; E Drexler; M Keilson; A Merriam; S Wassertheil-Smoller; V Spada
Journal:  N Engl J Med       Date:  1987-08-13       Impact factor: 91.245

10.  Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).

Authors:  J F Kurtzke
Journal:  Neurology       Date:  1983-11       Impact factor: 9.910
View more
  3 in total

1.  Disability outcome measures in therapeutic trials of relapsing-remitting multiple sclerosis: effects of heterogeneity of disease course in placebo cohorts.

Authors:  C Liu; L D Blumhardt
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-04       Impact factor: 10.154

2.  Randomised, double blind, placebo controlled study of interferon beta-1a in relapsing-remitting multiple sclerosis analysed by area under disability/time curves.

Authors:  C Liu; L D Blumhardt
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-10       Impact factor: 10.154

Review 3.  "Summary measure" statistic for assessing the outcome of treatment trials in relapsing-remitting multiple sclerosis.

Authors:  C Liu; A Li Wan Po; L D Blumhardt
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-06       Impact factor: 10.154
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.